Jacob Archer

2.0k total citations
21 papers, 798 citations indexed

About

Jacob Archer is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Jacob Archer has authored 21 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Jacob Archer's work include Immunotherapy and Immune Responses (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and HIV Research and Treatment (4 papers). Jacob Archer is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and HIV Research and Treatment (4 papers). Jacob Archer collaborates with scholars based in United States, Nepal and United Kingdom. Jacob Archer's co-authors include Suryaram Gummuluru, Steven C. Hatch, Jesse H. Erasmus, Amit P. Khandhar, Rhea N. Coler, Brian Granger, Neal Van Hoeven, John H. Connor, Javier Martínez‐Picado and Mar Naranjo‐Gómez and has published in prestigious journals such as Blood, Cancer Research and Journal of Virology.

In The Last Decade

Jacob Archer

21 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Archer United States 14 372 334 278 164 141 21 798
Jennifer Lu Australia 10 254 0.7× 273 0.8× 296 1.1× 281 1.7× 138 1.0× 14 803
William M. McDougall United States 10 421 1.1× 286 0.9× 129 0.5× 250 1.5× 260 1.8× 15 867
Xiǎolì Chī United States 9 181 0.5× 493 1.5× 355 1.3× 94 0.6× 286 2.0× 13 910
William E. Diehl United States 14 289 0.8× 307 0.9× 237 0.9× 346 2.1× 205 1.5× 24 814
Fengwen Xu China 17 529 1.4× 299 0.9× 568 2.0× 357 2.2× 298 2.1× 33 1.2k
Mariano Sánchez-Lockhart United States 19 179 0.5× 462 1.4× 322 1.2× 61 0.4× 117 0.8× 44 920
Gwen M. Taylor United States 13 180 0.5× 185 0.6× 162 0.6× 107 0.7× 155 1.1× 29 601
Stephanie Erbar Germany 13 524 1.4× 418 1.3× 246 0.9× 66 0.4× 238 1.7× 16 919
Justin A. Roby Australia 14 305 0.8× 446 1.3× 314 1.1× 56 0.3× 184 1.3× 33 987
Yaw Shin Ooi United States 12 455 1.2× 357 1.1× 173 0.6× 87 0.5× 157 1.1× 26 999

Countries citing papers authored by Jacob Archer

Since Specialization
Citations

This map shows the geographic impact of Jacob Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Archer more than expected).

Fields of papers citing papers by Jacob Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Archer. The network helps show where Jacob Archer may publish in the future.

Co-authorship network of co-authors of Jacob Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Archer. A scholar is included among the top collaborators of Jacob Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Archer. Jacob Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kasal, Darshan N., Madeleine F. Jennewein, Nathan Cross, et al.. (2025). A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses. Frontiers in Immunology. 16. 1569454–1569454. 3 indexed citations
2.
Archer, Jacob, Taishi Kimura, Katrina Nicholes, et al.. (2024). A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models. Science Translational Medicine. 16(759). eadi1625–eadi1625. 13 indexed citations
3.
Larsen, Sasha E., Jesse H. Erasmus, Valerie A. Reese, et al.. (2023). An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis. Vaccines. 11(1). 130–130. 41 indexed citations
4.
Kimura, Taishi, Joseph M. Leal, Bryan J. Berube, et al.. (2023). A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation. Molecular Therapy. 31(8). 2360–2375. 35 indexed citations
5.
Khandhar, Amit P., Chelsea D. Landon, Jacob Archer, et al.. (2023). Evaluation of repRNA vaccine for induction and in utero transfer of maternal antibodies in a pregnant rabbit model. Molecular Therapy. 31(4). 1046–1058. 8 indexed citations
6.
Mukherjee, Jean, Jacqueline M. Tremblay, Jacob Archer, et al.. (2022). Intramuscular delivery of formulated RNA encoding six linked nanobodies is highly protective for exposures to three Botulinum neurotoxin serotypes. Scientific Reports. 12(1). 11664–11664. 10 indexed citations
7.
Rais, Maham, Valerie A. Reese, Sasha E. Larsen, et al.. (2022). Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen. Tuberculosis. 138. 102302–102302. 14 indexed citations
8.
Leventhal, Shanna, Kimberly Meade‐White, Elaine Haddock, et al.. (2022). Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge. EBioMedicine. 82. 104188–104188. 46 indexed citations
9.
O’Connor, Megan A., Jesse H. Erasmus, Samantha Randall, et al.. (2021). A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques. Frontiers in Immunology. 12. 800723–800723. 10 indexed citations
10.
Voigt, Emily A., et al.. (2021). Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus. Molecular Therapy. 29(9). 2782–2793. 16 indexed citations
11.
Erasmus, Jesse H., Jacob Archer, Amit P. Khandhar, et al.. (2020). Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection. Molecular Therapy — Methods & Clinical Development. 18. 402–414. 83 indexed citations
12.
Maloney, Divine, et al.. (2019). Ethical Concerns of the Use of Virtual Avatars in Consumer Entertainment. 5. 1489–1492. 4 indexed citations
13.
Erasmus, Jesse H., Amit P. Khandhar, Jeff Guderian, et al.. (2018). A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika. Molecular Therapy. 26(10). 2507–2522. 118 indexed citations
14.
Wee, Edmund G., Beatrice Ondondo, Peter Berglund, et al.. (2017). HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells. Molecular Therapy. 25(2). 494–503. 18 indexed citations
15.
16.
Wen, Yingxia, James E. Monroe, Jacob Archer, et al.. (2014). Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice. Vaccine. 32(30). 3796–3804. 68 indexed citations
17.
Roberts, C Michael, et al.. (2009). Norovirus outbreaks on three college campuses - California, Michigan, and Wisconsin, 2008.. MMWR Morbidity and Mortality Weekly Report. 58(39). 1095–1100. 20 indexed citations
18.
Hatch, Steven C., Jacob Archer, & Suryaram Gummuluru. (2009). Glycosphingolipid Composition of Human Immunodeficiency Virus Type 1 (HIV-1) Particles Is a Crucial Determinant for Dendritic Cell-Mediated HIV-1 trans -Infection. Journal of Virology. 83(8). 3496–3506. 55 indexed citations
19.
Izquierdo‐Useros, Nuria, Mar Naranjo‐Gómez, Jacob Archer, et al.. (2008). Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood. 113(12). 2732–2741. 195 indexed citations
20.
Galbraith, N. S., et al.. (1961). Salmonella saint-paul infection in England and Wales in 1959. Journal of Hygiene. 59(2). 133–141. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Lu Breakdown of academic impact, for papers by William M. McDougall Breakdown of academic impact, for papers by Xiǎolì Chī Breakdown of academic impact, for papers by William E. Diehl Breakdown of academic impact, for papers by Fengwen Xu Breakdown of academic impact, for papers by Mariano Sánchez-Lockhart Breakdown of academic impact, for papers by Gwen M. Taylor Breakdown of academic impact, for papers by Stephanie Erbar Breakdown of academic impact, for papers by Justin A. Roby Breakdown of academic impact, for papers by Yaw Shin Ooi
Rankless by CCL
2026